Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure.

Singh KK, Shukla PC, Quan A, Desjardins JF, Lovren F, Pan Y, Garg V, Gosal S, Garg A, Szmitko PE, Schneider MD, Parker TG, Stanford WL, Leong-Poi H, Teoh H, Al-Omran M, Verma S.

J Biol Chem. 2012 Feb 24;287(9):6604-14. doi: 10.1074/jbc.M111.292664. Epub 2011 Dec 8.

2.

Clinical problem-solving. It's not all in your head.

Towns K, Szmitko PE, Smith C, Detsky AS, Mourad O.

N Engl J Med. 2011 Oct 6;365(14):1329-34. doi: 10.1056/NEJMcps0900533. No abstract available.

PMID:
21991955
3.

Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages.

Lovren F, Pan Y, Quan A, Szmitko PE, Singh KK, Shukla PC, Gupta M, Chan L, Al-Omran M, Teoh H, Verma S.

Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H656-63. doi: 10.1152/ajpheart.00115.2010. Epub 2010 Jul 9.

4.

Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease.

Gupta M, Szmitko PE, Tsigoulis M, Braga MF, Kajil M, Herjikaka S, Quan A, Teoh H, Verma S.

J Cardiovasc Pharmacol. 2010 Sep;56(3):241-5. doi: 10.1097/FJC.0b013e3181e7fd74.

PMID:
20505518
5.

The incretin system and cardiometabolic disease.

Szmitko PE, Leiter LA, Verma S.

Can J Cardiol. 2010 Feb;26(2):87-95. Review.

6.

Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.

Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S.

Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1440-9. doi: 10.1152/ajpendo.90780.2008. Epub 2009 Apr 7.

7.

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM.

CMAJ. 2009 Mar 31;180(7):713-8. doi: 10.1503/cmaj.082001. Epub 2009 Jan 28.

8.

Plasmodium falciparum malaria occurring 8 years after leaving an endemic area.

Szmitko PE, Kohn ML, Simor AE.

Diagn Microbiol Infect Dis. 2009 Jan;63(1):105-7. doi: 10.1016/j.diagmicrobio.2008.08.017. Epub 2008 Oct 21.

PMID:
18945569
9.

Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality.

Teoh H, Quan A, Bang KW, Wang G, Lovren F, Vu V, Haitsma JJ, Szmitko PE, Al-Omran M, Wang CH, Gupta M, Peterson MD, Zhang H, Chan L, Freedman J, Sweeney G, Verma S.

Am J Physiol Endocrinol Metab. 2008 Sep;295(3):E658-64. doi: 10.1152/ajpendo.90384.2008. Epub 2008 Jul 15.

10.

The endocannabinoid system and cardiometabolic risk.

Szmitko PE, Verma S.

Atherosclerosis. 2008 Aug;199(2):248-56. doi: 10.1016/j.atherosclerosis.2008.03.011. Epub 2008 Mar 20. Review.

PMID:
18440538
11.

Impaired endothelial function in C-reactive protein overexpressing mice.

Teoh H, Quan A, Lovren F, Wang G, Tirgari S, Szmitko PE, Szalai AJ, Ward ME, Verma S.

Atherosclerosis. 2008 Dec;201(2):318-25. doi: 10.1016/j.atherosclerosis.2008.02.034. Epub 2008 Mar 20.

PMID:
18433756
12.

C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile?

Szmitko PE, Verma S.

J Cardiometab Syndr. 2006 Winter;1(1):66-9; quiz 70-1. Review.

13.

C-reactive protein and reendothelialization: NO involvement.

Szmitko PE, Verma S.

Circ Res. 2007 May 25;100(10):1405-7. No abstract available.

PMID:
17525379
14.

Fetal exposure to ACE inhibitors increased risk of major congenital malformations.

Szmitko PE, Juurlink D.

Evid Based Med. 2007 Feb;12(1):26. No abstract available.

PMID:
17264274
15.

Review: nonselective nonsteroidal antiinflammatory drugs do not increase risk for cardiovascular events.

Szmitko PE, Juurlink D.

ACP J Club. 2007 Jan-Feb;146(1):12. No abstract available.

PMID:
17203932
16.

Adiponectin and cardiovascular disease: state of the art?

Szmitko PE, Teoh H, Stewart DJ, Verma S.

Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1655-63. Epub 2006 Dec 1. Review.

17.

Endothelial progenitor cell-coated stents under scrutiny.

Szmitko PE, Kutryk MJ, Stewart DJ, Strauss MH, Verma S.

Can J Cardiol. 2006 Nov;22(13):1117-9. No abstract available.

18.

Adiponectin and myocardial infarction: A paradox or a paradigm?

Teoh H, Strauss MH, Szmitko PE, Verma S.

Eur Heart J. 2006 Oct;27(19):2266-8. Epub 2006 Sep 7. No abstract available.

PMID:
16959802
19.

Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate.

Wang CH, Anderson N, Li SH, Szmitko PE, Cherng WJ, Fedak PW, Fazel S, Li RK, Yau TM, Weisel RD, Stanford WL, Verma S.

Circ Res. 2006 Sep 15;99(6):617-25. Epub 2006 Aug 24.

PMID:
16931795
20.

C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells.

Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S.

Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2476-82. Epub 2006 Aug 24.

PMID:
16931792
21.

C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells.

Zhong Y, Li SH, Liu SM, Szmitko PE, He XQ, Fedak PW, Verma S.

Hypertension. 2006 Sep;48(3):504-11. Epub 2006 Jul 17.

PMID:
16847147
22.

Does cannabis hold the key to treating cardiometabolic disease?

Szmitko PE, Verma S.

Nat Clin Pract Cardiovasc Med. 2006 Mar;3(3):116-7. No abstract available.

PMID:
16505839
23.
24.

C-reactive protein comes of age.

Verma S, Szmitko PE, Ridker PM.

Nat Clin Pract Cardiovasc Med. 2005 Jan;2(1):29-36; quiz 58. Review.

PMID:
16265340
25.

Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism.

Fedak PW, Szmitko PE, Weisel RD, Altamentova SM, Nili N, Ohno N, Verma S, Fazel S, Strauss BH, Li RK.

J Thorac Cardiovasc Surg. 2005 Nov;130(5):1430-9. Epub 2005 Oct 13.

26.

Can statin therapy alter the natural history of bicuspid aortic valves?

Verma S, Szmitko PE, Fedak PW, Errett L, Latter DA, David TE.

Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2547-9. No abstract available.

27.

C-reactive protein and statins: IL-8 as a molecular link?

Szmitko PE, Verma S.

Clin Sci (Lond). 2005 Jun;108(6):493-5.

PMID:
15799714
28.

Cardiology patient pages. Red wine and your heart.

Szmitko PE, Verma S.

Circulation. 2005 Jan 18;111(2):e10-1. No abstract available.

PMID:
15657377
29.

Antiatherogenic potential of red wine: clinician update.

Szmitko PE, Verma S.

Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2023-30. Epub 2005 Jan 14. Review.

30.

Adipokines: molecular links between obesity and atheroslcerosis.

Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S.

Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2031-41. Epub 2005 Jan 14. Review.

31.

Endothelial function: ready for prime time?

Verma S, Szmitko PE, Anderson TJ.

Can J Cardiol. 2004 Nov;20(13):1335-9. Review.

PMID:
15565197
32.

Should radial arteries be used routinely for coronary artery bypass grafting?

Verma S, Szmitko PE, Weisel RD, Bonneau D, Latter D, Errett L, LeClerc Y, Fremes SE.

Circulation. 2004 Aug 3;110(5):e40-6. Review. No abstract available.

PMID:
15289390
33.

C-reactive protein: structure affects function.

Verma S, Szmitko PE, Yeh ET.

Circulation. 2004 Apr 27;109(16):1914-7. No abstract available.

PMID:
15117860
34.

C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.

Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, Kutryk MJ.

Circulation. 2004 May 4;109(17):2058-67. Epub 2004 Apr 12.

PMID:
15078802
35.

Off-pump coronary artery bypass surgery: fundamentals for the clinical cardiologist.

Verma S, Fedak PW, Weisel RD, Szmitko PE, Badiwala MV, Bonneau D, Latter D, Errett L, LeClerc Y.

Circulation. 2004 Mar 16;109(10):1206-11. Review. No abstract available.

PMID:
15023895
36.

Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.

Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al-Omran M, Cherng WJ, Li RK, Stanford WL, Verma S.

Circulation. 2004 Mar 23;109(11):1392-400. Epub 2004 Mar 1.

PMID:
14993120
37.

C-reactive protein upregulates complement-inhibitory factors in endothelial cells.

Li SH, Szmitko PE, Weisel RD, Wang CH, Fedak PW, Li RK, Mickle DA, Verma S.

Circulation. 2004 Feb 24;109(7):833-6. Epub 2004 Feb 16.

PMID:
14967730
38.

Coxibs and the endothelium.

Verma S, Szmitko PE.

J Am Coll Cardiol. 2003 Nov 19;42(10):1754-6. No abstract available.

39.

Biomarkers of vascular disease linking inflammation to endothelial activation: Part II.

Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ, Verma S.

Circulation. 2003 Oct 28;108(17):2041-8. Review. No abstract available.

PMID:
14581382
40.

New markers of inflammation and endothelial cell activation: Part I.

Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S.

Circulation. 2003 Oct 21;108(16):1917-23. Review. No abstract available.

PMID:
14568885
41.

Endothelial progenitor cells: new hope for a broken heart.

Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S.

Circulation. 2003 Jun 24;107(24):3093-100. Review. No abstract available.

PMID:
12821589

Supplemental Content

Loading ...
Support Center